Anika Therapeutics (ANIK) Tops Q1 EPS by 13c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $14.65 +3.17%
Revenue Growth %: +3.5%
Financial Fact:
Income from operations: 13.69M
Today's EPS Names:
MAYS, CRMT, REPL, More
Revenue Growth %: +3.5%
Financial Fact:
Income from operations: 13.69M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Anika Therapeutics (NASDAQ: ANIK) reported Q1 EPS of ($0.11), $0.13 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $37.9 million versus the consensus estimate of $38.95 million.
For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- BofA lists top 5 themes driving next $1tn in incremental semi sales
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
